Brief: Core Laboratories NV Announces Revised Q1 2022 Guidance

Core Laboratories

16/03/2022 21:20

March 16 (Reuters) - Core Laboratories Nv  CLB.N :
    * CORE LAB ANNOUNCES REVISED Q1 2022 GUIDANCE
    * SEES Q1 2022 REVENUE $110 MILLION TO $113 MILLION
    * SEES Q1 2022 EARNINGS PER SHARE $0.05 TO $0.08
    * ON-GOING CONFLICT BETWEEN RUSSIA AND UKRAINE IS ALSO
ADVERSELY
IMPACTING BOTH SERVICE REVENUE AND PRODUCT SALES DURING Q1
    * EXPECTS SUPPLY LINES TO REALIGN, COMPANY'S ASSOCIATED
LABORATORY
SERVICES TO RESUME IN NEAR-TERM
    * CORE LAB- SUSPENDED LOCAL UKRAINIAN OPERATIONS, COMPLETION
PRODUCT SALES DELIVERED THROUGH PRODUCTION ENHANCEMENT SEGMENT
INTO UKRAINE ALSO BEEN SUSPENDED
    * Q1 EARNINGS PER SHARE VIEW $0.19, REVENUE VIEW $122.2
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nPn5plpF1a 
Further company coverage:  CLB.N 

 ((reuters.briefs@thomsonreuters.com;))